| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6830352 | Seizure | 2016 | 6 Pages |
Abstract
Overall, results confirmed the claimed role of SCN1A c.3184 A/G polymorphism in epilepsy and moreover in development of pharmacoresistance among Egyptian epileptic children. CYP3A5*3 variants have no contributing effect on pharmacoresistance among Egyptian epileptic children.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Wafaa Moustafa M. Abo El Fotoh, Sameh abd Allah Abd el naby, Mona Salah El-din Habib, Abeer Ahmed ALrefai, Zeinab A. Kasemy,